[go: up one dir, main page]

Samoszuk et al., 1998 - Google Patents

An immunofluorescent assay for acute promyelocytic leukemia cells

Samoszuk et al., 1998

View PDF
Document ID
12959042332088162521
Author
Samoszuk M
Tynan W
Sallash G
Nasr S
Monczak Y
Miller Jr W
Publication year
Publication venue
American journal of clinical pathology

External Links

Snippet

Sequential treatment with all-trans retinoic acid followed by chemotherapy significantly improves the long-term survival of patients who have acute promyelocytic leukemia (APL). Consequently, a simple and accurate test is needed to establish the diagnosis of APL and to …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Grosser et al. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes
Chan et al. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression
Berger et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.
Morton et al. Human osteosarcomas: immunologic evidence suggesting an associated infectious agent
US5834196A (en) Method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
Oldham et al. Cellular microcytotoxicity in human tumor systems: Analysis of results
De Waele et al. Immunogold staining method for the light microscopic detection of leukocyte cell surface antigens with monoclonal antibodies: its application to the enumeration of lymphocyte subpopulations.
Braylan et al. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood
JACKSON et al. Ia+ T cells in new onset Graves' disease
Janossy et al. Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies
Plaeger-Marshall et al. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping
Rennie et al. Evaluation of clinical methods for detecting proteinuria
Stahl et al. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP
Parker et al. Phagocytosis of particulate complexes of γ-globulin and rheumatoid factor
Bjorndahl et al. Human T cell activation: differential response to anti‐CD28 as compared to anti‐CD3 monoclonal antibodies
Sevéus et al. Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells
Nisengard et al. Diagnostic importance of immunofluorescence in oral bullous diseases and lupus erythematosus
Husby et al. Direct immunochemical detection of prostaglandin‐E and cyclic nucleotides in human malignant tumors
Williams et al. Lymphocytes binding C-reactive protein during acute rheumatic fever.
Steffelaar et al. Immune complex detection by immunofluorescence on peripheral blood polymorphonuclear leucocytes
Gopal et al. C-myc and c-myb expression in acute myelogenous leukemia
Samoszuk et al. An immunofluorescent assay for acute promyelocytic leukemia cells
US5968755A (en) Methods for determining T-cell profiles of immunocompromised subjects
Quagliata et al. Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpura
Yanagihara et al. Mycosis Fungoides/Sezary’s Syndrome Progressing to Immunoblastic Sarcoma. A T-Cell Lymphoproliferation with Both Helper and Suppressor Phenotypes